Update date
30 Jun 2023
Shareable Research Card
Surface Oncology, Inc. Assets
This metric view shows Surface Oncology, Inc. assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: Q2 2023
- Latest reported value
- $66,006,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2023
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: Q2 2023.
- Latest reported value on this page: $66,006,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Assets
Latest reported assets: $66,006,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
Q2 2023
SEC-backed company facts were refreshed from filings filed on 02 Aug 2023.
Benchmark Context
How Assets compares with peers
Surface Oncology, Inc. is outside the visible top 120 companies for assets in the current sample.
Compared with
Compared with 120 companies reporting assets in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Assets is down about 66% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2010 to 31 Mar 2026.
- Nearby companies in this sample: JPMORGAN CHASE & CO and FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Plain-English Guide
What Assets means
Total assets are the resources the company reports it owns or controls on the balance sheet.
Why people care
Users use assets for scale context and to compare a company’s operating base with its debt, equity, or cash generation.
How to read it
Treat assets as a balance-sheet snapshot, then compare them with revenue or cash flow to understand how productive that asset base looks.
Compare next
Compare it with debt, cash, and revenue when you want to understand scale, leverage, and asset intensity together.
Asset-heavy and asset-light business models are naturally different, so cross-company comparisons work best within similar industries.
Open a live SEC-backed example
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Financial Metric Page
Surface Oncology, Inc.: Assets
Latest period: Q2 2023. Period end: 30 Jun 2023. Units: USD. Frequency: quarterly.
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Metric Snapshot
- Latest value
- $66,006,000
- Coverage range
- 31 Dec 2017 - 30 Jun 2023
- Fact rows
- 23
What This Metric Tells You
- Shows the reported level of assets over 31 Dec 2017 - 30 Jun 2023.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 23 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use quarterly sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
Which companies report the largest asset base?
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | JPMORGAN CHASE & CO (jpm) | $4,900,475,000,000 | Instant - 31 Mar 2026 | Open JPMORGAN CHASE & CO Assets |
| 2 | FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE (fnma) | $4,314,635,000,000 | Instant - 31 Mar 2026 | Open FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE Assets |
| 3 | FEDERAL HOME LOAN MORTGAGE CORP (fmcc) | $3,497,598,000,000 | Instant - 31 Dec 2025 | Open FEDERAL HOME LOAN MORTGAGE CORP Assets |
| 4 | BANK OF AMERICA CORP /DE/ (bac) | $3,496,186,000,000 | Instant - 31 Mar 2026 | Open BANK OF AMERICA CORP /DE/ Assets |
| 5 | CITIGROUP INC (c) | $2,657,202,000,000 | Instant - 31 Dec 2025 | Open CITIGROUP INC Assets |
| 6 | WELLS FARGO & COMPANY/MN (wfc) | $2,205,752,000,000 | Instant - 31 Mar 2026 | Open WELLS FARGO & COMPANY/MN Assets |
Metric Details
- Metric
- Assets (Assets)
- Taxonomy
- us-gaap
- Units tracked
- USD
- Frequency coverage
- quarterly
- History range
- 31 Dec 2017 - 30 Jun 2023
- Facts on this page
- 23
- Description
- Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
- Metric-level SEC endpoint
- Open SEC company concept
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)
Surface Oncology, Inc. Quarterly Assets (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | $66,006,000 | -$127,973,000 | -66% | 30 Jun 2023 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q1 2023 | $137,008,000 | -$80,672,000 | -37% | 31 Mar 2023 | 10-Q | 04 May 2023 | 2023 | Q1 |
| Q4 2022 | $159,910,000 | -$30,937,000 | -16% | 31 Dec 2022 | 10-Q | 02 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $181,621,000 | -$6,991,000 | -3.7% | 30 Sep 2022 | 10-Q | 02 Nov 2022 | 2022 | Q3 |
| Q2 2022 | $193,979,000 | -$11,540,000 | -5.6% | 30 Jun 2022 | 10-Q | 03 Aug 2022 | 2022 | Q2 |
| Q1 2022 | $217,680,000 | +$2,934,000 | +1.4% | 31 Mar 2022 | 10-Q | 09 May 2022 | 2022 | Q1 |
| Q4 2021 | $190,847,000 | -$26,291,000 | -12% | 31 Dec 2021 | 8-K | 03 Jul 2023 | ||
| Q3 2021 | $188,612,000 | +$43,942,000 | +30% | 30 Sep 2021 | 10-Q | 04 Nov 2021 | 2021 | Q3 |
| Q2 2021 | $205,519,000 | +$50,993,000 | +33% | 30 Jun 2021 | 10-Q | 05 Aug 2021 | 2021 | Q2 |
| Q1 2021 | $214,746,000 | +$83,531,000 | +64% | 31 Mar 2021 | 10-Q | 05 May 2021 | 2021 | Q1 |
| Q4 2020 | $217,138,000 | +$85,445,000 | +65% | 31 Dec 2020 | 10-K | 02 Mar 2022 | 2021 | FY |
| Q3 2020 | $144,670,000 | +$5,694,000 | +4.1% | 30 Sep 2020 | 10-Q | 10 Nov 2020 | 2020 | Q3 |
| Q2 2020 | $154,526,000 | -$322,000 | -0.21% | 30 Jun 2020 | 10-Q | 11 Aug 2020 | 2020 | Q2 |
| Q1 2020 | $131,215,000 | -$39,393,000 | -23% | 31 Mar 2020 | 10-Q | 12 May 2020 | 2020 | Q1 |
| Q4 2019 | $131,693,000 | -$42,372,000 | -24% | 31 Dec 2019 | 10-K | 09 Mar 2021 | 2020 | FY |
| Q3 2019 | $138,976,000 | -$47,302,000 | -25% | 30 Sep 2019 | 10-Q | 12 Nov 2019 | 2019 | Q3 |
| Q2 2019 | $154,848,000 | -$47,285,000 | -23% | 30 Jun 2019 | 10-Q | 07 Aug 2019 | 2019 | Q2 |
| Q1 2019 | $170,608,000 | +$58,592,000 | +52% | 31 Mar 2019 | 10-Q | 09 May 2019 | 2019 | Q1 |
| Q4 2018 | $174,065,000 | +$92,611,000 | +114% | 31 Dec 2018 | 10-K | 10 Mar 2020 | 2019 | FY |
| Q3 2018 | $186,278,000 | 30 Sep 2018 | 10-Q | 13 Nov 2018 | 2018 | Q3 | ||
| Q2 2018 | $202,133,000 | 30 Jun 2018 | 10-Q | 14 Aug 2018 | 2018 | Q2 | ||
| Q1 2018 | $112,016,000 | 31 Mar 2018 | 10-Q | 29 May 2018 | 2018 | Q1 | ||
| Q4 2017 | $81,454,000 | 31 Dec 2017 | 10-K | 07 Mar 2019 | 2018 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.